Using Particles That Are Smaller Than the Head of a Pin to Treat Cancer
Thanks in part to research begun more than a decade ago with funding from Women’s Health Research at Yale, Dr. W. Mark Saltzman is working with colleagues on a way to deploy effective cancer-fighting medication safely with the help of nanoparticles.
Carocari Gift to Support Dr. Schwartz’s Ovarian Cancer Research
Deborah Carocari was only 36 when she was diagnosed with a rare form of advanced but low-grade ovarian cancer. At that time she received a prognosis of several months to a year from her physician, Peter Schwartz, MD, now the John Slade Ely Professor of Obstetrics, Gynecology, and Reproductive Sciences and Vice Chair, Gynecology. Debbie went on to defy those odds and battle the cancer for the next two decades. Although she ultimately succumbed to the disease, a generous gift from her estate is now making possible further ovarian cancer research by Dr. Schwartz.
Yale Cancer Center Scientists Build Genomic Research Platform to Help Treat Cervical Cancer
Yale Cancer Center scientists have built a powerful genomic research platform to study cervical cancer, a disease that often is untreatable if it progresses after surgery or primary chemo-radiation treatment.
Once-Common Hysterectomy Technique Linked to Worse Uterine Cancer Outcomes
Every year, nearly 700,000 American women have surgery to remove their uterus (hysterectomy) or uterine fibroids (myomectomy). A laparoscopic surgical technique once commonly used in these procedures could be worsening the outcomes for women who have undiagnosed uterine cancer at the time of the procedure, Yale Cancer Center scientists report in the Journal of Clinical Oncology.
Four Faculty Members Elected to the National Academy of Sciences
In recognition of their outstanding research achievements, four faculty members from the School of Medicine have been elected to the National Academy of Sciences (NAS). Akiko Iwasaki, PhD; Haifan Lin, PhD; David G. Schatz, PhD; and Günter Paul Wagner, PhD, were selected for one of the world’s highest honors that can be bestowed on a scientist.
Dr. Sangini S. Sheth selected as one of the ACOG 2018 Immunization Champion Award Winners
New for ACOG in 2018, the Immunization Champion Award recognizes members who have demonstrated exceptional progress in increasing immunization rates among women. The award is intended to recognize ob-gyns who are doing an exemplary job of going above and beyond to educate patients and other providers, as well as increasing access to immunizations in their practice, communities, and the nation. This year ACOG recognizes the hard work and dedication of three selected members who exemplify ACOG’s guidance on immunization for women, one of whom is Dr. Sanguine Sheith, MD from the Yale School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences.
$1.8 Million Granted to Yale School of Public Health to Study Effectiveness of HPV Vaccine
A $1.8 million National Institutes of Health grant will help researchers at the Yale School of Public Health shed light on the real-world effectiveness of the Human Papillomavirus (HPV) vaccine. Results of this study can ultimately help to maximize the vaccine’s impact on several types of cancer.
Researchers find genes behind aggressive ovarian and endometrial cancers
In a major breakthrough for ovarian and uterine cancers, Yale researchers have defined the genetic landscape of rare, highly aggressive tumors called carcinosarcomas (CSs), pointing the way to possible new treatments. The findings are published in the Oct. 10 online early edition of Proceedings of the National Academy of Sciences.
Fetal BPA exposure in mice linked to estrogen-related diseases after adolescence
Low levels of BPA exposure may be considered safe, but new research published online in The FASEB Journal, suggests otherwise. In the report, researchers from Yale show that the genome is permanently altered in the uterus of mice that had been exposed to BPA during their fetal development. These changes were found to mainly affect genes that are regulated by estrogen and are implicated in the formation of estrogen-related diseases such as infertility, endometriosis, endometrial cancer, osteoporosis, prostate cancer, neurodegenerative disease, obesity and breast cancer.Source: medicalxpress.com
Smilow doctor: Removing ovaries, fallopian tubes as Angelina Jolie did, ‘individualized’ decision
A woman deciding to having her ovaries and fallopian tubes removed, which Angelina Jolie revealed Tuesday that she had done, is a “very individualized” decision, according to Dr. Elena Ratner, assistant professor of obstetrics, gynecology at Smilow Cancer Hospital.Source: New Haven Register
Breast Cancer and Menopause
Think back to your PRE-menopause days. If someone told you they could trigger menopause for you, you'd hardly have jumped at the chance, right? But that's exactly what many cancer survivors younger than 50 -- or even younger than 40 -- experience.Source: The Huffington Post
Fighting breast cancer with an herb
A clinical trial underway at Smilow Cancer Hospital at Yale-New Haven Hospital is focusing on the link between an herb and fighting breast cancer. Black Cohosh is an herb you can easily purchase. It is generally used to ease symptoms for menopause, such as hot flashes.Source: HEALTH Magazine
Ideal gestational weight gain varies by pre-pregnancy BMI in twin pregnancy
For people giving birth to twins, the gestational weight gain range with the lowest risk for adverse perinatal outcomes was similar among those with a pre-pregnancy BMI of underweight or normal weight. However, the ideal range for gestational weight gain (GWG) for twin pregnancy decreased with each successively higher BMI category, data in JAMA Network Open showed. The data suggest that the current United States Institute of Medicine GWG recommendations should be lower.Source: Healio